| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX36 MYH3 MYH11 ABCA12 KIF4A MCM5 ZNFX1 RFC1 TRIP13 DNAH14 MYO3A MYH14 STARD9 DNAH17 DNAI2 MACF1 ABCC2 DDX21 DNAH8 DNAH9 TDRD12 | 4.43e-11 | 614 | 115 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH3 MYH11 KIF4A DNAH14 MYO3A MYH14 STARD9 DNAH17 DNAI2 DNAH8 DNAH9 | 8.11e-11 | 118 | 115 | 11 | GO:0003774 |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.55e-07 | 70 | 115 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 5.13e-07 | 28 | 115 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.00e-06 | 18 | 115 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | actin binding | MYH3 VPS18 MYH11 FMNL2 PTK2 FMNL3 LMOD3 MYO3A INF2 MYH14 MACF1 MICAL3 IQGAP3 | 3.91e-06 | 479 | 115 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH3 VPS18 MYH11 DCTN2 APC2 KIF4A CCDC88B FMNL2 PTK2 FMNL3 LMOD3 MYO3A BRCA1 INF2 MYH14 FAM161A STARD9 MACF1 MICAL3 IQGAP3 | 4.32e-06 | 1099 | 115 | 20 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DHX36 MYH3 ABCA12 MCM5 RFC1 TRIP13 MACF1 ABCC2 DDX21 DNAH8 DNAH9 TDRD12 | 9.17e-06 | 441 | 115 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | actin filament binding | 5.14e-05 | 227 | 115 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.95e-05 | 37 | 115 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 6.62e-05 | 38 | 115 | 4 | GO:0000146 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYBPH MYH3 MYH11 PPFIA1 FMNL2 CYRIB FMNL3 LMOD3 MYO3A CYRIA KANK1 INF2 MYH14 MICAL3 IQGAP3 | 3.26e-05 | 803 | 113 | 15 | GO:0030036 |
| GeneOntologyBiologicalProcess | microtubule-based process | DCTN2 IFT172 APC2 KIF4A CCDC88B CEP43 LDHC DNAH14 PTK2 BRCA1 STARD9 DNAH17 DNAI2 VPS13A MACF1 DNAH8 DNAH9 | 6.23e-05 | 1058 | 113 | 17 | GO:0007017 |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 6.25e-05 | 124 | 113 | 6 | GO:0007229 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYBPH KRT3 MYH3 KRT78 MYH11 IFT172 PPFIA1 APC2 CCDC88B CYRIB LMOD3 CYRIA KANK1 INF2 MICAL3 IQGAP3 | 6.59e-05 | 957 | 113 | 16 | GO:0097435 |
| GeneOntologyCellularComponent | supramolecular fiber | MYBPH KRT3 NES MYH3 VPS18 KRT78 MYH11 DCTN2 APC2 KIF4A TMEM214 DNAH14 LMOD3 MYO3A INF2 MYH14 FAM161A DNAH17 DNAI2 MACF1 DNAH8 DNAH9 RPL17 | 6.77e-08 | 1179 | 113 | 23 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYBPH KRT3 NES MYH3 VPS18 KRT78 MYH11 DCTN2 APC2 KIF4A TMEM214 DNAH14 LMOD3 MYO3A INF2 MYH14 FAM161A DNAH17 DNAI2 MACF1 DNAH8 DNAH9 RPL17 | 7.65e-08 | 1187 | 113 | 23 | GO:0099081 |
| GeneOntologyCellularComponent | outer dynein arm | 3.88e-07 | 12 | 113 | 4 | GO:0036157 | |
| GeneOntologyCellularComponent | dynein complex | 4.56e-07 | 54 | 113 | 6 | GO:0030286 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH3 VPS18 MYH11 KALRN DCTN2 APC2 CTTNBP2NL PTK2 MST1R LMOD3 MYO3A INF2 MYH14 MACF1 FERMT3 | 5.03e-07 | 576 | 113 | 15 | GO:0015629 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT3 NES VPS18 KRT78 DCTN2 APC2 KIF4A TMEM214 DNAH14 MYO3A INF2 FAM161A DNAH17 DNAI2 MACF1 DNAH8 DNAH9 | 6.60e-06 | 899 | 113 | 17 | GO:0099513 |
| GeneOntologyCellularComponent | axonemal dynein complex | 9.38e-06 | 25 | 113 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | myosin filament | 9.38e-06 | 25 | 113 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | microtubule associated complex | 2.75e-05 | 161 | 113 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | microtubule | DCTN2 APC2 KIF4A TMEM214 DNAH14 FAM161A DNAH17 DNAI2 MACF1 DNAH8 DNAH9 | 1.49e-04 | 533 | 113 | 11 | GO:0005874 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 2.90e-04 | 107 | 113 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 2.90e-04 | 107 | 113 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | myosin complex | 2.93e-04 | 59 | 113 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 2.93e-04 | 59 | 113 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 3.15e-04 | 238 | 113 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | actomyosin | 4.37e-04 | 117 | 113 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 4.55e-04 | 118 | 113 | 5 | GO:0032432 | |
| GeneOntologyCellularComponent | myosin II complex | 4.57e-04 | 28 | 113 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | motile cilium | 6.96e-04 | 355 | 113 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | midbody | 1.32e-03 | 222 | 113 | 6 | GO:0030496 | |
| Domain | P-loop_NTPase | DHX36 MYH3 MYH11 NWD1 ABCA12 KIF4A MCM5 ZNFX1 HNRNPUL1 RFC1 TRIP13 DNAH14 MYO3A MYH14 STARD9 ABCC2 PARPBP DDX21 DNAH8 DNAH9 GNL3 TDRD12 | 6.34e-09 | 848 | 113 | 22 | IPR027417 |
| Domain | ARM-type_fold | CAND2 IFT172 APC2 ZNFX1 FMNL2 PPP4R4 FMNL3 VAC14 URB1 PIK3C2A INF2 UTP20 | 1.01e-06 | 339 | 113 | 12 | IPR016024 |
| Domain | Drf_GBD | 1.76e-05 | 9 | 113 | 3 | PF06371 | |
| Domain | Drf_FH3 | 1.76e-05 | 9 | 113 | 3 | PF06367 | |
| Domain | FH3_dom | 1.76e-05 | 9 | 113 | 3 | IPR010472 | |
| Domain | GTPase-bd | 1.76e-05 | 9 | 113 | 3 | IPR010473 | |
| Domain | Drf_FH3 | 1.76e-05 | 9 | 113 | 3 | SM01139 | |
| Domain | Drf_GBD | 1.76e-05 | 9 | 113 | 3 | SM01140 | |
| Domain | GBD/FH3_dom | 3.43e-05 | 11 | 113 | 3 | IPR014768 | |
| Domain | GBD_FH3 | 3.43e-05 | 11 | 113 | 3 | PS51232 | |
| Domain | - | DHX36 NWD1 ABCA12 MCM5 ZNFX1 HNRNPUL1 RFC1 TRIP13 DNAH14 ABCC2 DDX21 DNAH8 DNAH9 GNL3 TDRD12 | 4.34e-05 | 746 | 113 | 15 | 3.40.50.300 |
| Domain | IQ | 7.03e-05 | 71 | 113 | 5 | PF00612 | |
| Domain | Dynein_heavy_chain_D4_dom | 7.48e-05 | 14 | 113 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 7.48e-05 | 14 | 113 | 3 | IPR024743 | |
| Domain | MT | 7.48e-05 | 14 | 113 | 3 | PF12777 | |
| Domain | AAA_8 | 7.48e-05 | 14 | 113 | 3 | PF12780 | |
| Domain | Myosin_head_motor_dom | 8.00e-05 | 38 | 113 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 8.00e-05 | 38 | 113 | 4 | PS51456 | |
| Domain | Myosin_head | 8.00e-05 | 38 | 113 | 4 | PF00063 | |
| Domain | MYSc | 8.00e-05 | 38 | 113 | 4 | SM00242 | |
| Domain | DHC_fam | 9.31e-05 | 15 | 113 | 3 | IPR026983 | |
| Domain | FH2 | 9.31e-05 | 15 | 113 | 3 | PS51444 | |
| Domain | Dynein_heavy | 9.31e-05 | 15 | 113 | 3 | PF03028 | |
| Domain | FH2_Formin | 9.31e-05 | 15 | 113 | 3 | IPR015425 | |
| Domain | FH2 | 9.31e-05 | 15 | 113 | 3 | PF02181 | |
| Domain | Myosin_N | 9.31e-05 | 15 | 113 | 3 | PF02736 | |
| Domain | Dynein_heavy_dom | 9.31e-05 | 15 | 113 | 3 | IPR004273 | |
| Domain | Myosin_N | 9.31e-05 | 15 | 113 | 3 | IPR004009 | |
| Domain | FH2 | 9.31e-05 | 15 | 113 | 3 | SM00498 | |
| Domain | IQ | 1.32e-04 | 81 | 113 | 5 | SM00015 | |
| Domain | Myosin_tail_1 | 1.65e-04 | 18 | 113 | 3 | PF01576 | |
| Domain | Myosin_tail | 1.65e-04 | 18 | 113 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.95e-04 | 19 | 113 | 3 | IPR027401 | |
| Domain | - | 1.95e-04 | 19 | 113 | 3 | 4.10.270.10 | |
| Domain | DUF1394 | 2.16e-04 | 4 | 113 | 2 | IPR009828 | |
| Domain | DUF1394 | 2.16e-04 | 4 | 113 | 2 | PF07159 | |
| Domain | IQ_motif_EF-hand-BS | 2.16e-04 | 90 | 113 | 5 | IPR000048 | |
| Domain | AAA | 2.43e-04 | 144 | 113 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 2.43e-04 | 144 | 113 | 6 | IPR003593 | |
| Domain | IQ | 2.52e-04 | 93 | 113 | 5 | PS50096 | |
| Domain | CH | 6.47e-04 | 65 | 113 | 4 | SM00033 | |
| Domain | CH | 8.57e-04 | 70 | 113 | 4 | PF00307 | |
| Domain | HEAT_REPEAT | 8.57e-04 | 70 | 113 | 4 | PS50077 | |
| Domain | - | 9.04e-04 | 71 | 113 | 4 | 1.10.418.10 | |
| Domain | DHC_N1 | 9.92e-04 | 8 | 113 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 9.92e-04 | 8 | 113 | 2 | IPR013594 | |
| Domain | CH | 1.00e-03 | 73 | 113 | 4 | PS50021 | |
| Domain | CH-domain | 1.11e-03 | 75 | 113 | 4 | IPR001715 | |
| Domain | GrpE_coiled_coil | 2.30e-03 | 12 | 113 | 2 | IPR013805 | |
| Domain | FERM_M | 2.71e-03 | 46 | 113 | 3 | PF00373 | |
| Domain | HEAT | 3.06e-03 | 48 | 113 | 3 | PF02985 | |
| Domain | Dynein_heavy_dom-2 | 3.15e-03 | 14 | 113 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.15e-03 | 14 | 113 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.15e-03 | 14 | 113 | 2 | IPR011704 | |
| Domain | TUDOR | 3.15e-03 | 14 | 113 | 2 | PF00567 | |
| Domain | AAA_5 | 3.15e-03 | 14 | 113 | 2 | PF07728 | |
| Domain | FERM_central | 3.24e-03 | 49 | 113 | 3 | IPR019748 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 3.44e-03 | 50 | 113 | 3 | IPR014352 | |
| Domain | FERM_1 | 3.44e-03 | 50 | 113 | 3 | PS00660 | |
| Domain | FERM_2 | 3.44e-03 | 50 | 113 | 3 | PS00661 | |
| Domain | FERM_3 | 3.44e-03 | 50 | 113 | 3 | PS50057 | |
| Domain | Band_41_domain | 3.44e-03 | 50 | 113 | 3 | IPR019749 | |
| Domain | B41 | 3.44e-03 | 50 | 113 | 3 | SM00295 | |
| Domain | Laminin_N | 4.12e-03 | 16 | 113 | 2 | IPR008211 | |
| Domain | LamNT | 4.12e-03 | 16 | 113 | 2 | SM00136 | |
| Domain | LAMININ_NTER | 4.12e-03 | 16 | 113 | 2 | PS51117 | |
| Domain | Laminin_N | 4.12e-03 | 16 | 113 | 2 | PF00055 | |
| Domain | WH2 | 4.12e-03 | 16 | 113 | 2 | PF02205 | |
| Domain | VWA | 4.74e-03 | 56 | 113 | 3 | PF00092 | |
| Domain | Integrin_alpha-2 | 5.21e-03 | 18 | 113 | 2 | IPR013649 | |
| Domain | PI3_PI4_kinase | 5.21e-03 | 18 | 113 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 5.21e-03 | 18 | 113 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 5.21e-03 | 18 | 113 | 2 | PS00916 | |
| Domain | INTEGRIN_ALPHA | 5.21e-03 | 18 | 113 | 2 | PS00242 | |
| Domain | Integrin_alpha2 | 5.21e-03 | 18 | 113 | 2 | PF08441 | |
| Domain | PI3/4_kinase_cat_dom | 5.21e-03 | 18 | 113 | 2 | IPR000403 | |
| Domain | Integrin_alpha | 5.21e-03 | 18 | 113 | 2 | IPR000413 | |
| Domain | PI3_4_KINASE_3 | 5.21e-03 | 18 | 113 | 2 | PS50290 | |
| Domain | HEAT | 5.23e-03 | 58 | 113 | 3 | IPR000357 | |
| Domain | Int_alpha | 5.80e-03 | 19 | 113 | 2 | SM00191 | |
| Domain | Int_alpha_beta-p | 5.80e-03 | 19 | 113 | 2 | IPR013519 | |
| Domain | BRCT | 5.80e-03 | 19 | 113 | 2 | PF00533 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 6.85e-07 | 27 | 90 | 5 | M47755 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 7.54e-06 | 43 | 90 | 5 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 9.47e-06 | 45 | 90 | 5 | M47670 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | 1.08e-04 | 15 | 90 | 3 | MM14643 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | 1.33e-04 | 16 | 90 | 3 | M639 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | 1.92e-04 | 18 | 90 | 3 | M645 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | 1.92e-04 | 18 | 90 | 3 | MM14642 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX36 EPRS1 NES EXOSC10 COPA KIF4A MCM5 HNRNPUL1 RFC1 TRIP13 PTK2 URB1 PTPN14 PIK3C2A INF2 MYH14 FANCI MACF1 UTP20 KDM2A DDX21 MVP GNL3 RPL9 RPL17 | 1.99e-12 | 1353 | 115 | 25 | 29467282 |
| Pubmed | DHX36 EPRS1 HNF1B VPS18 ZNF609 COPA DCTN2 LAMB1 KIF4A MCM5 HNRNPUL1 RFC1 TRIP13 TNRC18 KANK1 PTPN14 PIK3C2A INF2 MYH14 DDX21 MVP GNL3 RPL9 RPL17 | 2.53e-12 | 1247 | 115 | 24 | 27684187 | |
| Pubmed | EPRS1 KRT3 MYH3 MYH11 COPA PPFIA1 MCM5 STK31 TRIP13 LETM1 PPP4R4 LMOD3 TNRC18 BRCA1 MYH14 FAM161A STARD9 VPS13A PDIA2 MACF1 ABCC2 DDX21 DNAH8 RPL9 NSMCE4A | 7.89e-12 | 1442 | 115 | 25 | 35575683 | |
| Pubmed | DHX36 NES EXOSC10 COPA KIF4A MCM5 HNRNPUL1 RFC1 URB1 MYH14 FANCI MACF1 UTP20 DDX21 MVP GNL3 RPL9 | 5.78e-11 | 653 | 115 | 17 | 22586326 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPRS1 NES EXOSC10 CAND2 COPA DCTN2 MCM5 HNRNPUL1 RFC1 COPS2 TRIP13 BAP1 VAC14 FANCI MACF1 MICAL3 ENO2 IQGAP3 GNL3 RPL9 RPL17 | 1.83e-10 | 1149 | 115 | 21 | 35446349 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | ZNF609 COPA DCTN2 LAMB1 KIF4A HNRNPUL1 COPS2 CEP43 CTTNBP2NL BAP1 URB1 KANK1 INF2 KCTD5 MICAL3 DDX21 PMF1 IQGAP3 GNL3 NSMCE4A | 1.32e-09 | 1155 | 115 | 20 | 20360068 |
| Pubmed | DHX36 EPRS1 NES VPS18 KRT78 MYH11 COPA KALRN DCTN2 PPFIA1 RBP3 ZNFX1 FMNL2 LETM1 CYRIB TOMM70 INF2 MYH14 MACF1 MICAL3 ENO2 RPL17 | 1.61e-09 | 1431 | 115 | 22 | 37142655 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DHX36 EPRS1 EXOSC10 CAND2 COPA DCTN2 MCM5 HNRNPUL1 RFC1 TRIP13 CYRIB TOMM70 URB1 GET4 FANCI DDX21 IQGAP3 GNL3 RPL9 RPL17 | 5.55e-09 | 1257 | 115 | 20 | 37317656 |
| Pubmed | EPRS1 EXOSC10 COPA HNRNPUL1 RFC1 TRIP13 FMNL2 MYH14 MACF1 DDX21 MVP GNL3 RPL9 RPL17 | 1.31e-08 | 601 | 115 | 14 | 33658012 | |
| Pubmed | PI4K2B EXOSC10 CAND2 GALNT3 COPA DCTN2 LAMB1 MCM5 HNRNPUL1 RFC1 COPS2 TRIP13 LETM1 CYRIB TOMM70 URB1 PIK3C2A INF2 FANCI MICAL3 | 5.25e-08 | 1440 | 115 | 20 | 30833792 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EPRS1 MYH11 CAND2 COPA TMEM214 CACHD1 TRIP13 INTS8 TOMM70 VAC14 URB1 GET4 INF2 FANCI UTP20 IQGAP3 | 9.06e-08 | 942 | 115 | 16 | 31073040 |
| Pubmed | MYBPH MYH3 EXOSC10 CAND2 KALRN LAMA2 TOMM70 PIK3C2A MYH14 MACF1 KDM2A GNL3 | 1.04e-07 | 497 | 115 | 12 | 23414517 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | KRT78 ZNF609 COPA PPFIA1 PTK2 URB1 BRCA1 PIK3C2A MYH14 MACF1 KDM2A DDX21 RPL9 NSMCE4A | 1.30e-07 | 724 | 115 | 14 | 36232890 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DHX36 NES EXOSC10 COPA KIF4A MCM5 HNRNPUL1 RFC1 URB1 FANCI UTP20 KDM2A DDX21 GNL3 RPL9 RPL17 | 1.75e-07 | 989 | 115 | 16 | 36424410 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX36 EPRS1 COPA MCM5 HNRNPUL1 RFC1 TRIP13 LETM1 TOMM70 URB1 MYH14 FANCI STARD9 UTP20 DDX21 IQGAP3 GNL3 RPL9 RPL17 | 2.21e-07 | 1425 | 115 | 19 | 30948266 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DHX36 EXOSC10 COPA KIF4A HNRNPUL1 RFC1 URB1 MACF1 UTP20 DDX21 IQGAP3 GNL3 RPL9 NSMCE4A | 2.30e-07 | 759 | 115 | 14 | 35915203 |
| Pubmed | EPRS1 COPA KALRN IFT172 APC2 LAMB1 ZNFX1 CACHD1 HNRNPUL1 REV3L FMNL2 INTS8 PTK2 CYRIA MYH14 MACF1 RNF216 MVP | 2.34e-07 | 1285 | 115 | 18 | 35914814 | |
| Pubmed | DHX36 EPRS1 DCTN2 LAMB1 MCM5 RFC1 COPS2 CTTNBP2NL MACF1 MVP ENO2 RPL17 | 2.42e-07 | 538 | 115 | 12 | 28524877 | |
| Pubmed | DHX36 EPRS1 KRT3 MYH11 COPA DCTN2 MCM5 HNRNPUL1 GET4 MYH14 AP1S2 MACF1 DDX21 ENO2 GNL3 RPL9 RPL17 | 2.57e-07 | 1153 | 115 | 17 | 29845934 | |
| Pubmed | PI4K2B EPRS1 EXOSC10 COPA KIF4A MCM5 CCDC88B ACOX3 TOMM70 PIK3C2A MYH14 FANCI DDX21 MVP GNL3 RPL9 FERMT3 | 3.08e-07 | 1168 | 115 | 17 | 19946888 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.92e-07 | 202 | 115 | 8 | 33005030 | |
| Pubmed | 3.92e-07 | 202 | 115 | 8 | 24639526 | ||
| Pubmed | STAM2 EXOSC10 CAND2 DCTN2 PPFIA1 LAMB1 TMEM214 HNRNPUL1 LETM1 URB1 PTPN14 PIK3C2A INF2 VPS13A MACF1 DDX21 GNL3 RPL9 RPL17 | 4.23e-07 | 1487 | 115 | 19 | 33957083 | |
| Pubmed | 4.97e-07 | 47 | 115 | 5 | 8812413 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EXOSC10 COPA DCTN2 PPFIA1 KIF4A MCM5 TRIP13 INTS8 FANCI MACF1 DDX21 MVP | 5.56e-07 | 582 | 115 | 12 | 20467437 |
| Pubmed | The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. | 7.47e-07 | 220 | 115 | 8 | 31822558 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 7.73e-07 | 221 | 115 | 8 | 29991511 | |
| Pubmed | EPRS1 EXOSC10 COPA MCM5 HNRNPUL1 BRCA1 MYH14 DDX21 MVP RPL9 RPL17 | 8.02e-07 | 494 | 115 | 11 | 26831064 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX36 EPRS1 KRT3 EXOSC10 KRT78 COPA MCM5 HNRNPUL1 RFC1 PTPN14 UTP20 DDX21 MVP IQGAP3 GNL3 RPL9 RPL17 | 8.51e-07 | 1257 | 115 | 17 | 36526897 |
| Pubmed | VPS18 ABCA12 DCTN2 IFT172 APC2 MCM5 HNRNPUL1 CTTNBP2NL STARD9 PARPBP DDX21 | 1.16e-06 | 513 | 115 | 11 | 25798074 | |
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 31178125 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | EPRS1 STAM2 COPA DCTN2 PPFIA1 LAMB1 MCM5 HNRNPUL1 COPS2 TRIP13 CTTNBP2NL GET4 MYH14 FANCI MACF1 MVP ENO2 RPL17 | 1.40e-06 | 1455 | 115 | 18 | 22863883 |
| Pubmed | EPRS1 EXOSC10 COPA IFT172 MCM5 HNRNPUL1 TRIP13 FANCI DDX21 GNL3 RPL9 RPL17 | 1.45e-06 | 638 | 115 | 12 | 33239621 | |
| Pubmed | 1.46e-06 | 421 | 115 | 10 | 34650049 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 NES EXOSC10 KRT78 COPA MCM5 HNRNPUL1 TRIP13 URB1 MYH14 MACF1 UTP20 DDX21 GNL3 RPL9 | 1.51e-06 | 1024 | 115 | 15 | 24711643 |
| Pubmed | 2.21e-06 | 441 | 115 | 10 | 31239290 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NES KRT78 COPA DCTN2 MCM5 HNRNPUL1 RFC1 COPS2 CTTNBP2NL CYRIB TOMM70 PIK3C2A INF2 DDX21 MVP RPL9 RPL17 | 2.65e-06 | 1367 | 115 | 17 | 32687490 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KALRN POMGNT1 MCM5 REV3L ACOX3 BAP1 MST1R VAC14 URB1 TNRC18 GET4 INF2 FANCI MICAL3 IQGAP3 | 3.81e-06 | 1105 | 115 | 15 | 35748872 |
| Pubmed | DHX36 EPRS1 EXOSC10 DCTN2 RFC1 INTS8 URB1 MYH14 UTP20 DDX21 MVP RPL9 RPL17 | 4.81e-06 | 847 | 115 | 13 | 35850772 | |
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 5.58e-06 | 384 | 115 | 9 | 31059266 | |
| Pubmed | 5.58e-06 | 133 | 115 | 6 | 15144186 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EPRS1 EXOSC10 ZNF609 COPA KIF4A TMEM214 HNRNPUL1 RFC1 BAP1 URB1 BRCA1 UTP20 KDM2A DDX21 GNL3 RPL17 | 5.77e-06 | 1294 | 115 | 16 | 30804502 |
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 8.27e-06 | 217 | 115 | 7 | 31685992 | |
| Pubmed | 9.06e-06 | 408 | 115 | 9 | 33766124 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 9.42e-06 | 410 | 115 | 9 | 26949251 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 20081198 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 2991555 | ||
| Pubmed | Isolation and characterization of neural progenitor cells from post-mortem human cortex. | 1.08e-05 | 2 | 115 | 2 | 14648588 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 28439082 | ||
| Pubmed | Amygdala kindling induces nestin expression in the leptomeninges of the neocortex. | 1.08e-05 | 2 | 115 | 2 | 23305954 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 26118501 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 31751425 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 36550359 | ||
| Pubmed | Phase separation of DDX21 promotes colorectal cancer metastasis via MCM5-dependent EMT pathway. | 1.08e-05 | 2 | 115 | 2 | 37029300 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 37414201 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19445653 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 28327544 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 22790947 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24610946 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 9528852 | ||
| Pubmed | TRIP13 regulates progression of gastric cancer through stabilising the expression of DDX21. | 1.08e-05 | 2 | 115 | 2 | 39187490 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 35051358 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 29204984 | ||
| Pubmed | LAMB1 MCM5 HNRNPUL1 BRCA1 MYH14 FANCI DDX21 MVP GNL3 RPL9 RPL17 | 1.13e-05 | 652 | 115 | 11 | 31180492 | |
| Pubmed | DHX36 EPRS1 ZNF609 HNRNPUL1 RFC1 TNRC18 UTP20 DDX21 GNL3 RPL9 RPL17 | 1.18e-05 | 655 | 115 | 11 | 35819319 | |
| Pubmed | Expression of multiple formins in adult tissues and during developmental stages of mouse brain. | 1.25e-05 | 14 | 115 | 3 | 26272686 | |
| Pubmed | 1.25e-05 | 425 | 115 | 9 | 21081503 | ||
| Pubmed | NES COPA KIF4A MCM5 HNRNPUL1 FMNL2 PIK3C2A INF2 MACF1 KDM2A DDX21 | 1.26e-05 | 660 | 115 | 11 | 32780723 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ZNF609 COPA DCTN2 MCM5 COPS2 LDHC TOMM70 DDX21 ENO2 GNL3 RPL9 | 1.36e-05 | 665 | 115 | 11 | 30457570 |
| Pubmed | 1.39e-05 | 156 | 115 | 6 | 22952844 | ||
| Pubmed | EPRS1 EXOSC10 SCRN3 CAND2 PPFIA1 COPS2 LETM1 URB1 INF2 AEBP2 MACF1 PARPBP DDX21 ARHGEF6 | 1.44e-05 | 1084 | 115 | 14 | 11544199 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPRS1 MYH11 COPA HNRNPUL1 CYRIB TOMM70 GET4 MYH14 MACF1 IQGAP3 RPL9 RPL17 | 1.56e-05 | 807 | 115 | 12 | 30575818 |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 1.72e-05 | 558 | 115 | 10 | 27591049 | |
| Pubmed | 1.77e-05 | 244 | 115 | 7 | 29884807 | ||
| Pubmed | 1.83e-05 | 340 | 115 | 8 | 24332808 | ||
| Pubmed | EPRS1 COPA DCTN2 PPFIA1 MCM5 RFC1 PTPN14 KCTD5 DDX21 IQGAP3 GNL3 RPL9 RPL17 | 2.04e-05 | 971 | 115 | 13 | 33306668 | |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | 2.11e-05 | 454 | 115 | 9 | 33226137 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DHX36 EPRS1 VPS18 KRT78 KIF4A MCM5 HNRNPUL1 COPS2 PTK2 VAC14 GET4 KCTD5 FANCI DDX21 GNL3 | 2.25e-05 | 1284 | 115 | 15 | 17353931 |
| Pubmed | 2.32e-05 | 17 | 115 | 3 | 21983115 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 2.40e-05 | 580 | 115 | 10 | 35676659 | |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 2.40e-05 | 256 | 115 | 7 | 32698014 | |
| Pubmed | EPRS1 EXOSC10 COPA ZNFX1 TMEM214 TOMM70 MYH14 MACF1 DDX21 GNL3 RPL9 | 2.51e-05 | 711 | 115 | 11 | 33022573 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EPRS1 EXOSC10 MYH11 COPA DCTN2 MCM5 MYH14 MACF1 DDX21 ENO2 RPL9 RPL17 | 2.51e-05 | 847 | 115 | 12 | 35235311 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | DHX36 EPRS1 MYH11 DCTN2 MCM5 HNRNPUL1 CYRIB DDX21 GNL3 RPL9 RPL17 | 2.60e-05 | 714 | 115 | 11 | 28302793 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 2.81e-05 | 361 | 115 | 8 | 30344098 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.81e-05 | 361 | 115 | 8 | 26167880 | |
| Pubmed | DHX36 EPRS1 COPA DCTN2 MCM5 HNRNPUL1 TRIP13 DDX21 GNL3 RPL9 RPL17 | 2.99e-05 | 725 | 115 | 11 | 27025967 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 3.02e-05 | 179 | 115 | 6 | 36261009 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF609 H6PD TRIP13 INTS8 CEP43 DNAH14 PTK2 PPP4R4 TNRC18 INF2 MYH14 MACF1 KDM2A MICAL3 PMF1 GNL3 | 3.23e-05 | 1489 | 115 | 16 | 28611215 |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 10225960 | ||
| Pubmed | BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity. | 3.24e-05 | 3 | 115 | 2 | 19117993 | |
| Pubmed | Identification and characterization of human FMNL1, FMNL2 and FMNL3 genes in silico. | 3.24e-05 | 3 | 115 | 2 | 12684686 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 35261270 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 35843586 | ||
| Pubmed | FMNL2 and -3 regulate Golgi architecture and anterograde transport downstream of Cdc42. | 3.24e-05 | 3 | 115 | 2 | 28852060 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 3.42e-05 | 605 | 115 | 10 | 28977666 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 3.58e-05 | 486 | 115 | 9 | 30940648 | |
| Pubmed | EPRS1 COPA LAMB1 MCM5 TMEM214 CACHD1 H6PD COPS2 TRIP13 DDX21 | 3.82e-05 | 613 | 115 | 10 | 22268729 | |
| Pubmed | 3.85e-05 | 20 | 115 | 3 | 21689717 | ||
| Pubmed | Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. | 3.91e-05 | 57 | 115 | 4 | 17932509 | |
| Interaction | EED interactions | DHX36 EPRS1 VPS18 EXOSC10 MYH11 CAND2 COPA LAMB1 KIF4A MCM5 HNRNPUL1 INTS8 FMNL3 TOMM70 URB1 PTPN14 GET4 BRCA1 PIK3C2A AEBP2 MACF1 UTP20 KDM2A DDX21 MVP GNL3 RPL9 RPL17 | 5.78e-09 | 1445 | 114 | 28 | int:EED |
| Interaction | KIF23 interactions | DHX36 EPRS1 MYH11 COPA LAMA2 HNRNPUL1 RFC1 TRIP13 TOMM70 TNRC18 BRCA1 INF2 MYH14 MACF1 MICAL3 DDX21 MVP IQGAP3 GNL3 ARHGEF6 RPL9 RPL17 | 6.39e-08 | 1031 | 114 | 22 | int:KIF23 |
| Interaction | SIRT7 interactions | DHX36 NES EXOSC10 COPA KIF4A MCM5 HNRNPUL1 RFC1 URB1 MYH14 FANCI MACF1 UTP20 DDX21 MVP GNL3 RPL9 | 9.57e-07 | 744 | 114 | 17 | int:SIRT7 |
| Interaction | BAP1 interactions | EPRS1 NES HNF1B EXOSC10 CAND2 COPA DCTN2 MCM5 HNRNPUL1 RFC1 COPS2 TRIP13 BAP1 VAC14 BRCA1 FANCI MACF1 MICAL3 ENO2 IQGAP3 GNL3 RPL9 RPL17 | 1.03e-06 | 1314 | 114 | 23 | int:BAP1 |
| Interaction | CIT interactions | DHX36 NES EXOSC10 MYH11 COPA KALRN MCM5 TMEM214 HNRNPUL1 TRIP13 URB1 BRCA1 INF2 MYH14 FANCI MACF1 UTP20 KDM2A DDX21 GNL3 ARHGEF6 RPL9 RPL17 | 5.45e-06 | 1450 | 114 | 23 | int:CIT |
| Interaction | CDC5L interactions | EXOSC10 COPA KALRN DCTN2 PPFIA1 KIF4A MCM5 COPS2 TRIP13 INTS8 BAP1 BRCA1 FANCI MACF1 DDX21 MVP RPL9 | 6.21e-06 | 855 | 114 | 17 | int:CDC5L |
| Interaction | ECT2 interactions | DHX36 EPRS1 NES MYH11 COPA HNRNPUL1 TRIP13 INF2 MYH14 MACF1 UTP20 MICAL3 DDX21 MVP DNAH9 RPL9 RPL17 | 1.00e-05 | 887 | 114 | 17 | int:ECT2 |
| Interaction | STIP1 interactions | EPRS1 EXOSC10 COPA IFT172 MCM5 HNRNPUL1 TRIP13 PTK2 BAP1 PTPN14 BRCA1 FANCI DNAI2 DDX21 ENO2 GNL3 RPL9 RPL17 | 1.36e-05 | 1006 | 114 | 18 | int:STIP1 |
| Interaction | H2BC4 interactions | 1.67e-05 | 259 | 114 | 9 | int:H2BC4 | |
| Interaction | H1-4 interactions | DHX36 EPRS1 PPFIA1 MCM5 HNRNPUL1 REV3L RFC1 FMNL3 TNRC18 MACF1 DDX21 RPL9 NOTCH4 RPL17 | 2.03e-05 | 656 | 114 | 14 | int:H1-4 |
| Interaction | BRCA1 interactions | EPRS1 EXOSC10 COPA PPFIA1 POMGNT1 MCM5 HNRNPUL1 RFC1 CEP43 LDHC BAP1 BRCA1 MYH14 FAM161A FANCI RNF216 DDX21 MVP RPL9 RPL17 | 2.16e-05 | 1249 | 114 | 20 | int:BRCA1 |
| Interaction | LRRC31 interactions | 2.19e-05 | 205 | 114 | 8 | int:LRRC31 | |
| Interaction | KCTD13 interactions | DHX36 EPRS1 NES VPS18 MYH11 COPA KALRN DCTN2 PPFIA1 RBP3 ZNFX1 FMNL2 LETM1 CYRIB TOMM70 INF2 MYH14 MACF1 MICAL3 ENO2 RPL17 | 3.23e-05 | 1394 | 114 | 21 | int:KCTD13 |
| Interaction | HECTD1 interactions | DHX36 EPRS1 EXOSC10 COPA DCTN2 KIF4A HNRNPUL1 RFC1 URB1 PTPN14 MACF1 UTP20 DDX21 IQGAP3 GNL3 RPL9 NSMCE4A | 3.78e-05 | 984 | 114 | 17 | int:HECTD1 |
| Interaction | TARDBP interactions | DHX36 EXOSC10 HNRNPUL1 TRIP13 BAP1 GET4 BRCA1 DDX21 ENO2 GNL3 RPL9 RPL17 | 3.89e-05 | 520 | 114 | 12 | int:TARDBP |
| Interaction | PARP1 interactions | STAM2 HNF1B KIF4A MCM5 HNRNPUL1 RFC1 TRIP13 PTK2 BAP1 MST1R URB1 BRCA1 FANCI STARD9 UTP20 KDM2A DDX21 IQGAP3 GNL3 RPL9 | 4.53e-05 | 1316 | 114 | 20 | int:PARP1 |
| Interaction | C9orf72 interactions | DHX36 EPRS1 EXOSC10 CAND2 COPA DCTN2 MCM5 HNRNPUL1 RFC1 TRIP13 CYRIB TOMM70 URB1 GET4 FANCI DDX21 IQGAP3 GNL3 RPL9 RPL17 | 4.68e-05 | 1319 | 114 | 20 | int:C9orf72 |
| Interaction | RPL18A interactions | EXOSC10 RFC1 PTK2 BAP1 URB1 BRCA1 KCTD5 DDX21 GNL3 RPL9 RPL17 | 4.68e-05 | 447 | 114 | 11 | int:RPL18A |
| Interaction | TRIM31 interactions | DHX36 EPRS1 COPA ZNFX1 HNRNPUL1 MYH14 DDX21 GNL3 RPL9 RPL17 NSMCE4A | 5.38e-05 | 454 | 114 | 11 | int:TRIM31 |
| Interaction | RHOV interactions | 7.30e-05 | 243 | 114 | 8 | int:RHOV | |
| Interaction | PIP interactions | 7.69e-05 | 181 | 114 | 7 | int:PIP | |
| Interaction | MAFB interactions | 7.95e-05 | 246 | 114 | 8 | int:MAFB | |
| Interaction | LMBR1L interactions | EPRS1 MYH11 CAND2 COPA TMEM214 CACHD1 TRIP13 INTS8 TOMM70 VAC14 URB1 GET4 INF2 FANCI UTP20 IQGAP3 | 8.40e-05 | 946 | 114 | 16 | int:LMBR1L |
| Interaction | KIF20A interactions | NES MYH11 COPA APC2 MCM5 HNRNPUL1 TRIP13 URB1 BRCA1 PIK3C2A MYH14 FANCI MACF1 DDX21 GNL3 RPL9 RPL17 | 8.64e-05 | 1052 | 114 | 17 | int:KIF20A |
| Interaction | SSB interactions | DHX36 EPRS1 EXOSC10 HNRNPUL1 LDHC BAP1 TNRC18 BRCA1 MACF1 DDX21 RPL17 | 9.52e-05 | 484 | 114 | 11 | int:SSB |
| Interaction | GFI1B interactions | 1.24e-04 | 136 | 114 | 6 | int:GFI1B | |
| Interaction | RPL31 interactions | DHX36 EXOSC10 RFC1 BAP1 URB1 BRCA1 FANCI MACF1 UTP20 DDX21 GNL3 RPL9 RPL17 | 1.24e-04 | 680 | 114 | 13 | int:RPL31 |
| Interaction | YAP1 interactions | EPRS1 HNF1B EXOSC10 MYH11 COPA DCTN2 APC2 KIF4A HNRNPUL1 TNRC18 PTPN14 MYH14 KDM2A DDX21 ENO2 RPL9 RPL17 | 1.40e-04 | 1095 | 114 | 17 | int:YAP1 |
| Interaction | ENO1 interactions | ZNF609 MYH11 MCM5 ZNFX1 COPS2 BAP1 KANK1 BRCA1 MYH14 VPS13A KDM2A DNAH8 ENO2 | 1.68e-04 | 701 | 114 | 13 | int:ENO1 |
| Interaction | LARP7 interactions | DHX36 EPRS1 KRT3 MYH11 COPA DCTN2 HNRNPUL1 TRIP13 GET4 BRCA1 INF2 MYH14 DDX21 ENO2 GNL3 RPL9 RPL17 | 1.70e-04 | 1113 | 114 | 17 | int:LARP7 |
| Interaction | MAGEA9 interactions | 1.83e-04 | 208 | 114 | 7 | int:MAGEA9 | |
| Interaction | OPALIN interactions | 1.88e-04 | 209 | 114 | 7 | int:OPALIN | |
| Interaction | HEXIM1 interactions | DHX36 EPRS1 KRT3 COPA DCTN2 MCM5 HNRNPUL1 GET4 AP1S2 MACF1 DDX21 ENO2 GNL3 RPL9 RPL17 | 1.95e-04 | 913 | 114 | 15 | int:HEXIM1 |
| Interaction | IFI16 interactions | DHX36 EXOSC10 COPA DCTN2 HNRNPUL1 RFC1 URB1 BRCA1 INF2 MYH14 UTP20 DDX21 GNL3 | 2.01e-04 | 714 | 114 | 13 | int:IFI16 |
| Interaction | RPS24 interactions | DHX36 EXOSC10 BAP1 URB1 BRCA1 FANCI UTP20 DDX21 GNL3 RPL9 RPL17 | 2.07e-04 | 529 | 114 | 11 | int:RPS24 |
| Interaction | FAM167A interactions | 2.15e-04 | 96 | 114 | 5 | int:FAM167A | |
| Interaction | MEN1 interactions | DHX36 EPRS1 EXOSC10 ZNF609 DCTN2 RFC1 INTS8 URB1 MYH14 FANCI UTP20 KDM2A DDX21 MVP RPL9 RPL17 | 2.20e-04 | 1029 | 114 | 16 | int:MEN1 |
| Interaction | BRD7 interactions | DHX36 HNF1B EXOSC10 HNRNPUL1 RFC1 TRIP13 FMNL2 BRCA1 DDX21 ENO2 IQGAP3 GNL3 | 2.62e-04 | 637 | 114 | 12 | int:BRD7 |
| Interaction | SNRNP40 interactions | ZNF609 HNRNPUL1 RFC1 COPS2 URB1 BRCA1 PRPF40B FANCI KDM2A DDX21 GNL3 RPL9 | 2.62e-04 | 637 | 114 | 12 | int:SNRNP40 |
| Interaction | CAMK2D interactions | 2.72e-04 | 222 | 114 | 7 | int:CAMK2D | |
| Interaction | SLFN11 interactions | 2.88e-04 | 376 | 114 | 9 | int:SLFN11 | |
| Interaction | RPL14 interactions | REV3L PTK2 BAP1 URB1 BRCA1 STARD9 MACF1 DDX21 GNL3 RPL9 RPL17 | 3.07e-04 | 554 | 114 | 11 | int:RPL14 |
| Interaction | NFX1 interactions | DHX36 EPRS1 EXOSC10 DCTN2 APC2 HNRNPUL1 KCTD5 GNL3 RPL9 RPL17 | 3.16e-04 | 466 | 114 | 10 | int:NFX1 |
| Interaction | MYH9 interactions | MYH11 MCM5 COPS2 LETM1 BAP1 TNRC18 BRCA1 PIK3C2A INF2 MYH14 MACF1 MICAL3 MVP | 3.39e-04 | 754 | 114 | 13 | int:MYH9 |
| GeneFamily | Dyneins, axonemal | 8.32e-09 | 17 | 79 | 5 | 536 | |
| GeneFamily | Myosin heavy chains | 3.52e-05 | 15 | 79 | 3 | 1098 | |
| GeneFamily | Laminin subunits | 1.21e-03 | 12 | 79 | 2 | 626 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.36e-03 | 50 | 79 | 3 | 1293 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 1.61e-03 | 53 | 79 | 3 | 103 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.76e-03 | 18 | 79 | 2 | 1160 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 3.40e-03 | 20 | 79 | 2 | 548 | |
| Coexpression | FISCHER_DREAM_TARGETS | KIF4A MCM5 ZNFX1 RFC1 TRIP13 BRCA1 ZNF45 FAM161A FANCI RMND1 PARPBP DDX21 PMF1 IQGAP3 GNL3 NSMCE4A | 5.23e-06 | 969 | 115 | 16 | M149 |
| Coexpression | MANALO_HYPOXIA_DN | 5.86e-06 | 292 | 115 | 9 | M18562 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS | 7.88e-06 | 107 | 115 | 6 | M39165 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 1.02e-05 | 237 | 115 | 8 | M15606 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | NES KIF4A MCM5 TRIP13 PPP4R4 FMNL3 MYO3A BRCA1 FAM161A FANCI MICAL3 PARPBP | 1.10e-05 | 588 | 115 | 12 | M38992 |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 1.12e-05 | 240 | 115 | 8 | MM976 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_DN | 1.50e-05 | 180 | 115 | 7 | M2961 | |
| Coexpression | FUJII_YBX1_TARGETS_DN | 2.44e-05 | 194 | 115 | 7 | M14340 | |
| Coexpression | GSE18281_CORTEX_VS_MEDULLA_THYMUS_DN | 2.60e-05 | 196 | 115 | 7 | M7243 | |
| Coexpression | GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP | 2.96e-05 | 200 | 115 | 7 | M6555 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 2.96e-05 | 200 | 115 | 7 | M3188 | |
| Coexpression | BHATTACHARYA_EMBRYONIC_STEM_CELL | 3.49e-05 | 84 | 115 | 5 | M4282 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | EPRS1 LAMB1 POMGNT1 KIF4A RFC1 COPS2 FMNL2 INTS8 CYRIB TOMM70 PTPN14 BRCA1 PIK3C2A ZNF45 FANCI PARPBP DDX21 IQGAP3 | 4.09e-05 | 1407 | 115 | 18 | M14427 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 7.22e-05 | 402 | 115 | 9 | MM454 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | EPRS1 EXOSC10 KIF4A MCM5 TMEM214 RFC1 TRIP13 CEP43 LETM1 BAP1 TOMM70 GET4 BRCA1 FANCI PARPBP GNL3 NSMCE4A | 9.34e-05 | 1363 | 115 | 17 | M45782 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | SCRN3 PPFIA1 USP46 COPS2 INTS8 CTTNBP2NL TOMM70 PIK3C2A VPS13A RPL17 | 1.05e-04 | 523 | 115 | 10 | M12707 |
| Coexpression | KRIEG_HYPOXIA_NOT_VIA_KDM3A | HNF1B MCM5 CACHD1 RFC1 TRIP13 LDHC PTPN14 FANCI AP1S2 KDM2A MICAL3 ENO2 | 1.10e-04 | 746 | 115 | 12 | M2469 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.21e-04 | 250 | 115 | 7 | M11318 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | SCRN3 PPFIA1 USP46 COPS2 INTS8 CTTNBP2NL TOMM70 PIK3C2A VPS13A RPL17 | 1.25e-04 | 534 | 115 | 10 | MM1054 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | PI4K2B DHX36 EPRS1 PPFIA1 FPGT REV3L RFC1 BRCA1 AP1S2 PARPBP DDX21 | 1.50e-04 | 656 | 115 | 11 | M18979 |
| Coexpression | GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_UP | 1.51e-04 | 181 | 115 | 6 | M2994 | |
| Coexpression | GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN | 1.70e-04 | 185 | 115 | 6 | M2965 | |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 1.80e-04 | 187 | 115 | 6 | M6807 | |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | 1.93e-04 | 458 | 115 | 9 | M8520 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | 2.36e-04 | 578 | 115 | 10 | M2368 | |
| Coexpression | GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 2.38e-04 | 197 | 115 | 6 | M8980 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 2.58e-04 | 200 | 115 | 6 | M5041 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP | 2.58e-04 | 200 | 115 | 6 | M6553 | |
| Coexpression | GSE27786_LIN_NEG_VS_CD8_TCELL_UP | 2.58e-04 | 200 | 115 | 6 | M4775 | |
| Coexpression | GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN | 2.58e-04 | 200 | 115 | 6 | M7833 | |
| Coexpression | GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP | 2.58e-04 | 200 | 115 | 6 | M5627 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_1_DN | 2.69e-04 | 378 | 115 | 8 | M17788 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-07 | 169 | 115 | 7 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-07 | 179 | 115 | 7 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-07 | 186 | 115 | 7 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-07 | 186 | 115 | 7 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.10e-07 | 193 | 115 | 7 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.10e-07 | 193 | 115 | 7 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 7.35e-07 | 194 | 115 | 7 | a8ae49157ca3f9e8b3f1750a995aee012dc859b6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.35e-07 | 194 | 115 | 7 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 7.88e-07 | 196 | 115 | 7 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.88e-07 | 196 | 115 | 7 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.15e-07 | 197 | 115 | 7 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.43e-07 | 198 | 115 | 7 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | (3)_DC_Monocyte_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.43e-07 | 198 | 115 | 7 | e2b89f6d7c0007ccab62495cd543fe0e5513a9a4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 9.02e-07 | 200 | 115 | 7 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 9.02e-07 | 200 | 115 | 7 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells-Neuroepithelial_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 9.02e-07 | 200 | 115 | 7 | 2938a029fa0478be561574ace91f95c4a528b2d4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells|3m / Sample Type, Dataset, Time_group, and Cell type. | 9.02e-07 | 200 | 115 | 7 | cfe017b4a4d604a553d0a3df9659687f38e9a7af | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.02e-07 | 200 | 115 | 7 | 5b014c658eecc5e73679e5feb7a2aaa3d297001d | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-06 | 141 | 115 | 6 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-06 | 141 | 115 | 6 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-06 | 167 | 115 | 6 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-06 | 168 | 115 | 6 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-06 | 174 | 115 | 6 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-06 | 177 | 115 | 6 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-06 | 177 | 115 | 6 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 6.94e-06 | 178 | 115 | 6 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.16e-06 | 179 | 115 | 6 | 80112c686a8f85ad5e3cda6e3f3d3d51cf688092 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-06 | 182 | 115 | 6 | bc6a120dedc813c58baac1428c39851a07b71ba7 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 7.88e-06 | 182 | 115 | 6 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 8.13e-06 | 183 | 115 | 6 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.38e-06 | 184 | 115 | 6 | fa38d6a8709f520a027ad7e3ff783c84187ec467 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-T_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-06 | 184 | 115 | 6 | 185b49630da61cbf45c0926d1b992943296d2a54 | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 8.38e-06 | 184 | 115 | 6 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.38e-06 | 184 | 115 | 6 | a0831e850bc0b585296ed350fdd075c1f730308e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-06 | 184 | 115 | 6 | e7b9c69fc77040c5191ad8089697051e2589c30e | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 8.65e-06 | 185 | 115 | 6 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-06 | 185 | 115 | 6 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-06 | 186 | 115 | 6 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-06 | 186 | 115 | 6 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 187 | 115 | 6 | e53471c3e146a6f54788d81ecc469aba55b051bb | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 187 | 115 | 6 | 3d7d51fbadb20dc884d0b3c0d61b80f022b19d09 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 187 | 115 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 9.77e-06 | 189 | 115 | 6 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-05 | 190 | 115 | 6 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.01e-05 | 190 | 115 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.01e-05 | 190 | 115 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.04e-05 | 191 | 115 | 6 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 1.04e-05 | 191 | 115 | 6 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-05 | 191 | 115 | 6 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-05 | 191 | 115 | 6 | b85a0978dc1e8af4f49423f56dcfd52efce09ed1 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 192 | 115 | 6 | 96f23d6e8604d1cb24910d3118d8171b57c93e14 | |
| ToppCell | Proliferating|World / shred by cell class for mouse tongue | 1.07e-05 | 192 | 115 | 6 | f081f3f957cc782294e118fcc1055f6a4264ee98 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-05 | 193 | 115 | 6 | a332dfdcc48c405020014e644aa4d14fda98cc86 | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.10e-05 | 193 | 115 | 6 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 1.10e-05 | 193 | 115 | 6 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.10e-05 | 193 | 115 | 6 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 194 | 115 | 6 | 2cac1b9c4da01faaec9a67ec06f47a7060760225 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.13e-05 | 194 | 115 | 6 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.13e-05 | 194 | 115 | 6 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.13e-05 | 194 | 115 | 6 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.13e-05 | 194 | 115 | 6 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 194 | 115 | 6 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.13e-05 | 194 | 115 | 6 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 194 | 115 | 6 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.13e-05 | 194 | 115 | 6 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.13e-05 | 194 | 115 | 6 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.13e-05 | 194 | 115 | 6 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.13e-05 | 194 | 115 | 6 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.13e-05 | 194 | 115 | 6 | 635d0e88f9c542a1d9363066c6cdbc6e44db76c1 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.13e-05 | 194 | 115 | 6 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-05 | 194 | 115 | 6 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.17e-05 | 195 | 115 | 6 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.17e-05 | 195 | 115 | 6 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-05 | 195 | 115 | 6 | 4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-05 | 195 | 115 | 6 | 7a32a8535c29b819dacba901d0658280a2631c94 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.17e-05 | 195 | 115 | 6 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.17e-05 | 195 | 115 | 6 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 195 | 115 | 6 | 75759fd7f925725f0ecd07214afcca5aa2158f9e | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 195 | 115 | 6 | b57132802cb977551e214880984f3edcd375474f | |
| ToppCell | mild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.17e-05 | 195 | 115 | 6 | 9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.17e-05 | 195 | 115 | 6 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-05 | 196 | 115 | 6 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.20e-05 | 196 | 115 | 6 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.20e-05 | 196 | 115 | 6 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.20e-05 | 196 | 115 | 6 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(I)|lymph-node_spleen / Manually curated celltypes from each tissue | 1.20e-05 | 196 | 115 | 6 | 32d54c0b487f00c4f8bd765462e484da8a6625c9 | |
| ToppCell | Healthy-T/NK_proliferative|Healthy / disease group, cell group and cell class | 1.20e-05 | 196 | 115 | 6 | 91e44aabb2e85dcc77ddae6f7e000118d45d1de6 | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.24e-05 | 197 | 115 | 6 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.24e-05 | 197 | 115 | 6 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-SEP / Disease, Lineage and Cell Type | 1.24e-05 | 197 | 115 | 6 | 908e91fa16134b61943aea5e8fc0d6fbac8a8c6e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.24e-05 | 197 | 115 | 6 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-05 | 197 | 115 | 6 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | 1.24e-05 | 197 | 115 | 6 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.24e-05 | 197 | 115 | 6 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(I)|GI_large-bowel / Manually curated celltypes from each tissue | 1.24e-05 | 197 | 115 | 6 | 80a0cfbd454409594effead7082586b06c2f411a | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.24e-05 | 197 | 115 | 6 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.27e-05 | 198 | 115 | 6 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 1.27e-05 | 198 | 115 | 6 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-05 | 198 | 115 | 6 | 6a10bb81817ab606f1f5a2bd8cfe77ef2fb3f2fb | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.27e-05 | 198 | 115 | 6 | 8afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 5.20e-05 | 19 | 114 | 3 | DOID:10003 (implicated_via_orthology) | |
| Disease | skin neoplasm | 1.97e-04 | 74 | 114 | 4 | EFO_0004198 | |
| Disease | Lissencephaly | 2.20e-04 | 6 | 114 | 2 | C0266463 | |
| Disease | mean corpuscular hemoglobin concentration | KALRN HNRNPUL1 RFC1 TRIP13 INTS8 OR6P1 CYRIB LMOD3 CYRIA VPS13A PDIA2 MACF1 ENO2 | 3.48e-04 | 1105 | 114 | 13 | EFO_0004528 |
| Disease | cholestasis (implicated_via_orthology) | 5.23e-04 | 9 | 114 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | Fanconi anemia (is_implicated_in) | 6.52e-04 | 10 | 114 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | PR interval | 6.91e-04 | 495 | 114 | 8 | EFO_0004462 | |
| Disease | Retinitis Pigmentosa | 7.22e-04 | 104 | 114 | 4 | C0035334 | |
| Disease | Alzheimer disease, dementia, family history of Alzheimer’s disease | 8.56e-04 | 48 | 114 | 3 | EFO_0009268, MONDO_0001627, MONDO_0004975 | |
| Disease | Malignant neoplasm of breast | KALRN APC2 LAMA2 H6PD BAP1 PTPN14 BRCA1 MACF1 UTP20 RMND1 DNAH9 NOTCH4 | 9.29e-04 | 1074 | 114 | 12 | C0006142 |
| Disease | Congenital muscular dystrophy | 9.52e-04 | 12 | 114 | 2 | cv:C0699743 | |
| Disease | inflammatory biomarker measurement, YKL40 measurement | 1.02e-03 | 51 | 114 | 3 | EFO_0004869, EFO_0004872 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 1.12e-03 | 13 | 114 | 2 | C3501611 | |
| Disease | keratinocyte carcinoma | 1.16e-03 | 118 | 114 | 4 | EFO_0010176 | |
| Disease | phenylalanine measurement | 1.27e-03 | 55 | 114 | 3 | EFO_0005001 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 1.31e-03 | 14 | 114 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 1.50e-03 | 15 | 114 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | 1.64e-03 | 702 | 114 | 9 | C0009402 | |
| Disease | muscular dystrophy (is_implicated_in) | 1.94e-03 | 17 | 114 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Prostate cancer, familial | 2.44e-03 | 69 | 114 | 3 | C2931456 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.65e-03 | 148 | 114 | 4 | C0279702 | |
| Disease | Nonsyndromic genetic hearing loss | 3.22e-03 | 76 | 114 | 3 | cv:C5680182 | |
| Disease | Nasopharyngeal carcinoma | 3.25e-03 | 22 | 114 | 2 | C2931822 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELEARDLVIEALKAQ | 21 | Q9P2B4 | |
| EEEAEAEAVAALLLN | 46 | Q6ZN18 | |
| AALEEDAQILKVIEA | 651 | Q15052 | |
| GVLEASKALLEEQLE | 361 | A6NC98 | |
| KELNIDVADVESLLV | 376 | P61201 | |
| SQLKDDAVALVDVIA | 631 | O15254 | |
| GLDAVELLKQIDELD | 881 | Q86UK0 | |
| LKALVELDVDIEALN | 126 | Q5TZF3 | |
| IAKDAAQVILSAIDE | 246 | Q5VU97 | |
| ELLALLKCVEAEIAN | 631 | Q92560 | |
| AKVSALDLAVLDQVE | 266 | Q13561 | |
| ELAVDLEALVSKAEE | 536 | Q9GZS0 | |
| NILENSEALELVKEA | 216 | P09104 | |
| AELKDVLSLDDEVLQ | 596 | Q149M9 | |
| LKEQAADSILVLEAA | 191 | Q75QN2 | |
| DTVKALLVLLDEEAA | 351 | Q9NWS1 | |
| LKAIEQADLLQEEAE | 131 | P56377 | |
| LLVLSQAEKVLEEVD | 1086 | Q9NVI1 | |
| LEREQALAKEFAEIL | 121 | Q9H0Q0 | |
| DTLDLNAEEKAVLIA | 631 | Q7RTP6 | |
| LQLLEEAAKEVADEV | 96 | P33992 | |
| DEILANLSAEELKEL | 21 | Q0VAK6 | |
| LQAKVDALIDEIDFL | 321 | P12035 | |
| LIAEEGVDSLNVKEL | 361 | O95202 | |
| DQLLAEEKAAVLRAV | 1471 | Q7Z406 | |
| IALELLDSKFADQEV | 941 | O00443 | |
| AQALLDEKQAELDKV | 3311 | Q96JB1 | |
| LDATLNVIKEGEDLI | 691 | O60229 | |
| LEAVLNALDKIVEEG | 101 | Q6P1K2 | |
| VKALEEQNELLSAEL | 26 | P48681 | |
| EIVKLLLDADVCNVD | 1176 | Q14678 | |
| LALKDAQAKVDELEA | 366 | Q8N1N4 | |
| LKDLADELALVDVAL | 41 | P07864 | |
| DKDQLVLNIEALRAE | 496 | Q13136 | |
| ADLDSIEAVANEVLK | 1516 | P07942 | |
| QKEIAEDELVAAEAL | 1736 | P24043 | |
| KILVLDEATAAVDLE | 1456 | Q92887 | |
| NVTDEAALKDIVDAL | 331 | Q9UKX5 | |
| IIIAELDATANELDA | 441 | Q13087 | |
| LLIQLEAFEEAKAED | 241 | Q27J81 | |
| LVELLEKEEVQAGVA | 351 | Q86VI3 | |
| LKAQALAIETEAELQ | 746 | Q14764 | |
| ALSELVANAELLEEL | 6876 | Q9UPN3 | |
| LNLDLVKEAIDAFIE | 1356 | Q9UG01 | |
| LDQLITVADLELKDE | 1996 | Q9UMZ3 | |
| IQDLIDDKDALVFVL | 236 | Q15645 | |
| VLGDVNEDKLIDVAI | 526 | Q13349 | |
| IDDEEFLIKIAAIDN | 331 | Q8TCG2 | |
| DKEQAELVDFLLALV | 191 | Q8NGX9 | |
| NAKVADVLDVLNEVD | 406 | P38398 | |
| LEDKFDLLVDANDVI | 106 | Q01780 | |
| KLALAVARIDQLVED | 846 | O95996 | |
| GIEDEDALIADVKIL | 481 | Q9Y2K7 | |
| DALIADVKILLEELA | 486 | Q9Y2K7 | |
| ELRAAVFLALEEQEK | 36 | O95684 | |
| DGLEDQLLAAVVAKE | 3556 | Q9UFH2 | |
| GNIEIALEAAKALDD | 656 | P53621 | |
| LLKEIILVDDASVDE | 216 | Q14435 | |
| EDDKVDLNLIVALIR | 466 | Q9H2U1 | |
| AAAVSLENVLLDVKE | 836 | Q8IVF7 | |
| AAAVSLENVLLDVKE | 891 | Q96PY5 | |
| IVALNALDKADVAEL | 2351 | Q0VDD8 | |
| KVIEASDVVLEVLDA | 136 | Q9BVP2 | |
| DLLEDRKILAQDVAQ | 766 | O95239 | |
| LVINKDLAEEGVLEE | 111 | Q9NXV2 | |
| VVLKDAEGILEDLQS | 41 | Q9NUQ9 | |
| AEDNFVLKVVQLEEL | 2126 | Q9NYC9 | |
| LIEEKGAVEALAAAL | 601 | Q9NR30 | |
| LKALAAAEAILEDEE | 36 | Q3B820 | |
| EELISKLANDIEATA | 561 | O95479 | |
| EDVAVQLEALDILSD | 146 | O75155 | |
| ALEKELQAALTADEK | 11 | Q8IW40 | |
| DIVAITAADEKQELA | 51 | O14772 | |
| DVEAFQQELALLKIE | 86 | Q96GU1 | |
| KAELAERLQAALEAE | 26 | Q9BUJ2 | |
| ILKELQALNTEEAAE | 91 | P35680 | |
| FLIDDAVVKDEALAI | 431 | O75691 | |
| DEVILKDLEVLAEIA | 456 | Q08AM6 | |
| ITNALSEEDKEALIA | 1311 | P07814 | |
| LLQDESLEVLDALID | 441 | Q6NUP7 | |
| AEVEVADELLENLAK | 96 | Q7L5D6 | |
| EAIAKQLQLDEDAEL | 201 | P35251 | |
| LILDEVEVLFLEANE | 571 | Q587J7 | |
| DTAEKALNVIVDLLE | 121 | Q0VDG4 | |
| AKFAVVLEEDLDIAV | 386 | Q8WZA1 | |
| ALAVDAKNLLDVIDQ | 1026 | Q05397 | |
| DLALEEAVLEELTQK | 171 | Q15678 | |
| EIKLNSELDLDDAIL | 286 | Q9NWS8 | |
| EDLEAKAVIDILVIE | 251 | Q13203 | |
| LEKADIQLALEEAEA | 1536 | P11055 | |
| EDILNAGDKLTEVLE | 101 | Q9NXX6 | |
| AAEVDQELVELLVKE | 276 | Q9NWF9 | |
| NAELKGLDVDSLVIE | 101 | P18621 | |
| QVAEKELEASVALDA | 711 | Q9P2P6 | |
| LAVEDLVEELIAAQA | 1711 | Q99466 | |
| ADDDLVADLVVNILK | 351 | O60287 | |
| IAALEAKIAQLEEQV | 1816 | P35749 | |
| LEIALVDQGDADKEI | 566 | Q9BXU1 | |
| QALEKLEAAESLVLE | 1366 | O15417 | |
| KAELAEQEIAVALQD | 2516 | Q96RL7 | |
| IVLAEEALDKAQEVL | 616 | P10745 | |
| KVEEALINEEAILNL | 371 | O60673 | |
| KDELILEGNDIELVS | 141 | P32969 | |
| AVDLALQVDVDLAKQ | 726 | Q9P253 | |
| LEEALKALDVADLQK | 111 | Q6NUQ4 | |
| VGNLIIDLDADLEKD | 31 | O15014 | |
| ELSELNVKVLEALEL | 346 | O75886 | |
| KILLDQVEEAVADFD | 411 | O94826 | |
| DLDDLEVLVKQEAAG | 166 | Q6NWY9 | |
| DDLDVALSNLEVKLE | 321 | Q86UX7 | |
| LLEEKALLDQVDISF | 171 | B3SHH9 | |
| SLIEIAEEADLIQAD | 821 | Q9P2E3 | |
| LFDDDIVEKIDAQAI | 326 | P62068 | |
| LLALLQAEGAKIEED | 106 | Q9H9H4 | |
| DLDSALLAEVKDVLI | 1061 | Q04912 | |
| KDVAVVFSEEELQLL | 11 | Q02386 | |
| NLKDVDDLATLEILD | 336 | Q8NEV4 |